Pharmaceutical

Digital cognitive assessments and blood-based biomarkers in Alzheimer’s research

Apr 4, 2025 - 06:00
Digital cognitive assessments and blood-based biomarkers in Alzheimer’s research

Read the original article

Tags:

Previous Article

NBE Therapeutics opens ADC research facility in Switzerland

Next Article

FDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditions

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Ohio has enshrined the right to an abortion. But major obstacles remain for patients and providers

Opinion: Ohio has enshrined the right to an abortion. B...

Nov 13, 2023

Bayer in batteries: theme innovation strategy

Aug 1, 2024

MBX-1416 by MBX Biosciences Inc for Hypoglycemia: Likel...

Nov 4, 2023